Sun Pharmaceutical Industries Ltd (SUNPHARMA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7200
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company carries out product development, process chemistry, and manufacture of complex active pharmaceutical ingredients (APIs), over-the-counter products and formulations. It offers drugs in various dosage forms such as tablets, capsules, injectables, inhalers, ointments, creams and liquids. The company has manufacturing facilities in North America, Latin America, EMEA and Asia Pacific. Sun Pharma is headquartered in Mumbai, Maharashtra, India.

Sun Pharmaceutical Industries Ltd (SUNPHARMA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sun Pharmaceutical Industries Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
scPharma Raises USD45.6 Million in Series B Financing 10
Partnerships 12
InSite Vision Plans To Enter Into Licensing Agreement For DuraSite 2, Ophthalmic Drug Delivery System 12
Equity Offering 13
Sun Pharma Advanced Plans to Raise Additional Funds in Rights Offering of Shares 13
Sun Pharma Advanced Research Completes Rights Issue Of Shares For US$36 Million 14
Debt Offering 16
Sun Pharma Plans to Raise USD1.8 Billion in Private Placement of Debentures 16
Acquisition 17
Sun Pharma Acquires Pharmalucence, Provider of Injectable Pharma Products 17
Sun Pharmaceutical Industries Ltd – Key Competitors 18
Sun Pharmaceutical Industries Ltd – Key Employees 19
Sun Pharmaceutical Industries Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 27
Recent Developments 28
Financial Announcements 28
Aug 14, 2018: Sun Pharma reports Q1FY19 results 28
May 25, 2018: Sun Pharma reports Q4 & FY18 results 30
Feb 14, 2018: Sun Pharma reports Q3FY18 results 32
Nov 14, 2017: Sun Pharma reports Q2FY18 results 34
Aug 11, 2017: Sun Pharma reports Q1FY18 results 36
May 26, 2017: Sun Pharma reports Q4 & FY17 results 38
Feb 14, 2017: Sun Pharma reports Q3FY17 results 40
Corporate Communications 42
Jul 12, 2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director 42
Legal and Regulatory 43
Jun 12, 2018: Sun Pharma receives EIR for Halol facility 43
Feb 23, 2018: Sun Pharmaceutical Industries: Update on US FDA Halol Inspection 44
Mar 14, 2017: Sun Pharma Provides Update on Mohali Facility 45
Mar 14, 2017: Sun Pharmaceutical Industries Provides Update on Mohali Facility 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
Sun Pharmaceutical Industries Ltd, Medical Equipment, Key Facts, 2018 2
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sun Pharmaceutical Industries Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sun Pharmaceutical Industries Ltd, Deals By Market, 2012 to YTD 2018 8
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
scPharma Raises USD45.6 Million in Series B Financing 10
InSite Vision Plans To Enter Into Licensing Agreement For DuraSite 2, Ophthalmic Drug Delivery System 12
Sun Pharma Advanced Plans to Raise Additional Funds in Rights Offering of Shares 13
Sun Pharma Advanced Research Completes Rights Issue Of Shares For US$36 Million 14
Sun Pharma Plans to Raise USD1.8 Billion in Private Placement of Debentures 16
Sun Pharma Acquires Pharmalucence, Provider of Injectable Pharma Products 17
Sun Pharmaceutical Industries Ltd, Key Competitors 18
Sun Pharmaceutical Industries Ltd, Key Employees 19
Sun Pharmaceutical Industries Ltd, Subsidiaries 20
Sun Pharmaceutical Industries Ltd, Joint Venture 27

List of Figures
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sun Pharmaceutical Industries Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sun Pharmaceutical Industries Ltd (SUNPHARMA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bend Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Bend Research Inc (Bend Research), a subsidiary of Capsugel Inc is a provider of drug delivery technologies and formulation development services. The company offers services such as formulation science, dosage form development, process development, engineering, cGMP manufacturing, bioprocess …
  • Teva Pharmaceutical Industries Ltd (TEVA)-医療機器分野:企業M&A・提携分析
    Summary Teva Pharmaceutical Industries Ltd (Teva) carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines in central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company off …
  • Seven & i Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bangladesh Power Development Board-エネルギー分野:企業M&A・提携分析
    Summary Bangladesh Power Development Board (BPDB) is an integrated energy statutory board. It generates electricity through owned power plants and procures electricity from public and private generation companies. The board utilizes gas, coal, hydro, furnace oil, and diesel as fuel source for electr …
  • Clark Construction Group, LLC:企業の戦略的SWOT分析
    Clark Construction Group, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Alimentation Couche-Tard Inc. (ATD.B)-石油・ガス分野:企業M&A・提携分析
    Summary Alimentation Couche-Tard Inc. (Couche-Tard) is a retail company that operates an extensive network of convenience stores. The company principally offers food and non-food items as well as transportation fuels. Couche-Tard products include tobacco, alcohol, grocery items, candy, snacks and va …
  • Active Motif Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products include extracts, antibodies, reporter assays, fluorescent dyes, kits, cell, acid, and tissue extracts, molecules and recombinant proteins, among others. It of …
  • Vascutek Ltd:製品パイプライン分析
    Summary Vascutek Ltd (Vascutek), a subsidiary of Terumo Corp is a medical equipment company that designs, manufactures and distributes vascular and cardiovascular products. The company provides products such as stent graft system, aortic root designs, polyester products and EPTFE products, among oth …
  • The Jackson Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary The Jackson Laboratory (JAX) is a biomedical research center that offers clinical genomic solutions. The center provides breeding and rederivation services. It offers cryopreservation and recovery services such as sperm cryopreservation, on-site sperm cryopreservation, embryo cryopreservatio …
  • Tokyo Gas Co Ltd (9531):電力:M&Aディール及び事業提携情報
    Summary Tokyo Gas Co Ltd (Tokyo Gas) is a gas utility that produces, supplies and markets liquefied natural gas (LNG). It also produces, supplies and sells electricity. Tokyo Gas also has overseas upstream, midstream and downstream businesses. It provides engineering solutions, gas appliances and ga …
  • CGN New Energy Holdings Co Ltd (1811):企業の財務・戦略的SWOT分析
    CGN New Energy Holdings Co Ltd (1811) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Alphanosos SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alphanosos SAS (Alphanosos) is a developer of novel therapies for the treatment of chronic inflammatory diseases. The company offers pure antibiofilms and antibiotics. It concentrates on bacterial biofilms in various therapeutic areas such as dermatological, bucco-dental and respiratory dise …
  • 220 Laboratories Inc.:企業の戦略・SWOT・財務情報
    220 Laboratories Inc. - Strategy, SWOT and Corporate Finance Report Summary 220 Laboratories Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Yanmar Co Ltd:企業の戦略的SWOT分析
    Yanmar Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Genentech, Inc.:企業の戦略・SWOT・財務情報
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Asian Citrus Holdings Ltd (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Al Taif Technical Services PJSC:企業の戦略・SWOT・財務分析
    Al Taif Technical Services PJSC - Strategy, SWOT and Corporate Finance Report Summary Al Taif Technical Services PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Trimble Inc:企業の戦略・SWOT・財務情報
    Trimble Inc - Strategy, SWOT and Corporate Finance Report Summary Trimble Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Martifer SGPS SA (MAR):企業の財務・戦略的SWOT分析
    Martifer SGPS SA (MAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • ifa systems AG (IS8):企業の財務・戦略的SWOT分析
    ifa systems AG (IS8) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆